Enhanced STAT5A/B activation is achieved by copy number gains, enhanced protein expression, or gain-of-function (GOF) mutations, leading to higher pYSTAT5A/B levels contributing to tumor cell survival and disease progression. This evidence concerns the gene STAT5A and neoplasm.